ADMS
COM:ADAMASPHARMA
Supernus Pharmaceuticals
- Stock
Last Close
8.22
01/01 00:00
Volume Today
3.15M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 852K - | 3.41M 300.53% | 5.19M 52.21% | 6.28M 20.92% | |||||
average payables | 2.68M - | 2.89M 8.03% | 3.37M 16.52% | 3.32M 1.42% | 3.73M 12.44% | 5.22M 39.92% | 6.75M 29.23% | 4.54M 32.78% | |
average receivables | 509.50K - | 326.50K 35.92% | 3.05M 834.30% | 3.27M 7.18% | 1.17M 64.28% | 3.86M 230.69% | 6.69M 73.20% | 8.16M 22.00% | |
book value per share | 6.11 - | 9.91 62.18% | 6.42 35.28% | 6.09 5.10% | 2.93 51.85% | 3.34 14.05% | -0.03 100.97% | -1.42 4,304.47% | |
capex per share | -0.01 - | -0.09 595.66% | -0.08 10.81% | -0.07 3.17% | -0.06 25.45% | -0.04 29.04% | -0.00 98.36% | ||
capex to depreciation | -2.53 - | -8.29 227.64% | -3.22 61.21% | -2.01 37.50% | -1.05 47.58% | -0.73 30.83% | -0.01 97.97% | ||
capex to operating cash flow | -0.01 - | -0.05 687.29% | 0.03 160.41% | 0.03 14.01% | 0.02 44.28% | 0.01 45.77% | 0.00 97.82% | ||
capex to revenue | -0.00 - | -0.02 879.57% | -0.73 3,073.30% | -2.84 288.84% | -2.20 22.40% | -0.03 98.58% | -0.00 98.95% | ||
cash per share | 6.38 - | 8.25 29.21% | 5.90 28.50% | 5.23 11.23% | 7.69 46.88% | 7.84 2.01% | 4.79 38.91% | 2.37 50.52% | |
days of inventory on hand | 36.59K - | 2.95K 91.93% | 778.64 73.63% | 1.31K 67.77% | |||||
days payables outstanding | 83.26K - | 3.79K 95.45% | 1.02K 72.95% | 383.98 62.53% | |||||
days sales outstanding | 0.66 - | 3.42 417.12% | 1.06K 30,921.72% | 613.86 42.22% | 878.30 43.08% | 68.09 92.25% | 46.96 31.03% | 45.56 2.98% | |
debt to assets | 0.05 - | 0.09 78.48% | 0.10 11.37% | 0.07 25.94% | 0.64 792.80% | 0.62 4.28% | 1.01 62.91% | 1.42 40.86% | |
debt to equity | 0.05 - | 0.10 86.01% | 0.11 12.60% | 0.08 27.96% | 1.82 2,232.12% | 1.61 11.19% | -182.59 11,424.11% | -3.40 98.14% | |
dividend yield | |||||||||
earnings yield | 0.27 - | 0.04 85.36% | -0.10 354.61% | -0.16 62.07% | -0.12 28.48% | -0.57 387.40% | -1.00 75.76% | -0.38 62.41% | |
enterprise value | 102.32M - | 196.27M 91.83% | 479.80M 144.46% | 343.18M 28.47% | 775.82M 126.07% | 292.12M 62.35% | 166.84M 42.89% | 210.58M 26.22% | |
enterprise value over ebitda | 1.79 - | 11.06 516.84% | -8.47 176.62% | -5.78 31.76% | -9.09 57.18% | -2.64 70.89% | -1.88 29.07% | -4.86 159.14% | |
ev to operating cash flow | 3.82 - | 7.49 96.27% | -10.16 235.63% | -7.14 29.75% | -11.61 62.61% | -2.80 75.86% | -2.07 26.31% | -4.15 101.07% | |
ev to sales | 1.44 - | 3.51 144.20% | 250.42 7,025.19% | 599.97 139.59% | 1.36K 126.46% | 8.58 99.37% | 3.05 64.41% | 2.83 7.39% | |
free cash flow per share | 1.99 - | 1.68 15.45% | -2.68 259.87% | -2.29 14.72% | -3.02 31.87% | -3.92 29.75% | -2.92 25.45% | -1.44 50.61% | |
free cash flow yield | 0.14 - | 0.10 31.80% | -0.09 198.06% | -0.14 42.90% | -0.09 34.24% | -0.46 414.89% | -0.77 67.98% | -0.33 56.77% | |
graham net net | 6.07 - | 7.32 20.54% | 5.43 25.78% | 4.79 11.78% | 2.45 48.89% | 2.73 11.21% | -0.81 129.88% | -2.16 165.46% | |
graham number | 22.85 - | 12.40 45.74% | 20.32 63.91% | 19.47 4.20% | 16.18 16.90% | 19.14 18.35% | 1.66 91.32% | 7.22 334.94% | |
income quality | 0.53 - | 2.56 386.82% | 0.91 64.43% | 0.80 12.18% | 0.75 6.70% | 0.80 6.54% | 0.77 3.47% | 0.88 15.03% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 11.62 - | -18.93 - | -6.02 68.17% | -6.13 1.77% | -3.34 45.59% | ||||
interest debt per share | 0.37 - | 4.76 - | 5.14 8.08% | 5.16 0.34% | 4.07 21.05% | ||||
inventory turnover | 0.01 - | 0.12 1,139.00% | 0.47 279.24% | 0.28 40.40% | |||||
invested capital | 1.55 - | 1.33 14.63% | -143.02 10,891.69% | -2.60 98.18% | |||||
market cap | 187.93M - | 257.72M 37.14% | 512.90M 99.02% | 366.92M 28.46% | 764.49M 108.36% | 229.61M 69.97% | 104.90M 54.31% | 152.27M 45.17% | |
net current asset value | 81.78M - | 109.41M 33.79% | 100.63M 8.03% | 106.70M 6.03% | 59.13M 44.59% | 83.44M 41.13% | -12.73M 115.26% | -58.27M 357.69% | |
net debt to ebitda | -1.50 - | -3.46 130.79% | 0.58 116.89% | 0.40 31.59% | -0.13 133.19% | -0.57 326.51% | -0.70 23.06% | -1.35 93.26% | |
net income per share | 3.80 - | 0.69 81.85% | -2.86 515.12% | -2.77 3.29% | -3.97 43.41% | -4.87 22.82% | -3.80 22.00% | -1.63 57.05% | |
operating cash flow per share | 2.00 - | 1.77 11.64% | -2.61 247.65% | -2.21 15.07% | -2.96 33.81% | -3.88 30.85% | -2.92 24.71% | -1.44 50.60% | |
payables turnover | 0.00 - | 0.10 2,097.85% | 0.36 269.68% | 0.95 166.88% | |||||
receivables turnover | 551.12 - | 106.58 80.66% | 0.34 99.68% | 0.59 73.07% | 0.42 30.11% | 5.36 1,189.96% | 7.77 45.00% | 8.01 3.07% | |
research and ddevelopement to revenue | 0.10 - | 0.39 275.56% | 18.73 4,686.08% | 54.60 191.43% | 47.58 12.85% | 1.15 97.57% | 0.55 52.38% | 0.13 76.19% | |
return on tangible assets | 0.59 - | 0.06 89.26% | -0.40 734.42% | -0.42 4.76% | -0.48 14.03% | -0.56 16.06% | -0.65 16.27% | -0.48 26.27% | |
revenue per share | 5.30 - | 3.76 28.98% | 0.11 97.19% | 0.03 75.10% | 0.03 3.92% | 1.27 4,902.70% | 1.97 55.89% | 2.12 7.26% | |
roe | 0.62 - | 0.07 88.81% | -0.45 741.43% | -0.45 1.91% | -1.35 197.86% | -1.46 7.69% | 117.79 8,182.13% | 1.15 99.02% | |
roic | -0.64 - | 0.31 148.58% | -0.88 382.03% | -0.67 24.03% | 258.26 38,886.71% | -1.00 100.39% | -3.90 289.58% | 1.74 144.57% | |
sales general and administrative to revenue | 0.09 - | 0.28 195.44% | 12.24 4,319.17% | 53.02 333.04% | 107.38 102.53% | 3.21 97.01% | 2.09 34.70% | 1.43 31.45% | |
shareholders equity per share | 6.11 - | 9.91 62.18% | 6.42 35.28% | 6.09 5.10% | 2.93 51.85% | 3.34 14.05% | -0.03 100.97% | -1.42 4,304.47% | |
stock based compensation to revenue | 0.01 - | 0.13 1,332.78% | 5.20 3,928.73% | 18.48 255.66% | 23.41 26.67% | 0.46 98.02% | 0.24 49.27% | 0.09 63.28% | |
tangible asset value | 81.99M - | 147.07M 79.39% | 116.19M 21.00% | 132.18M 13.77% | 66.13M 49.97% | 89.89M 35.93% | -893K 100.99% | -49.98M 5,496.42% | |
tangible book value per share | 6.11 - | 9.91 62.18% | 6.42 35.28% | 6.09 5.10% | 2.93 51.85% | 3.34 14.05% | -0.03 100.97% | -1.42 4,304.47% | |
working capital | 81.79M - | 110.98M 35.69% | 101.38M 8.65% | 107.24M 5.78% | 162.57M 51.59% | 204.10M 25.55% | 123.37M 39.55% | 76.87M 37.69% |
All numbers in USD (except ratios and percentages)